Removal of Antiretroviral Products from the WHO List of Prequalified Medicines

Information and Guidance for Regulatory Bodies, National AIDS Programmes, Doctors and Patients


ANNEX 1: ALTERNATIVE PREQUALIFIED MEDICINES AND SUPPLIERS

  • Lamivudine 150 mg plus zidovudine 300 mg tablet (GSK), blister (60), bottle (60)

  • Lamivudine 150 mg plus zidovudine 300 mg tablet (Hetero), blister (10), bottle (60)

  • Lamivudine 150mg plus stavudine 40 mg and nevirapine 200 mg tablet (CIPLA), bottle (60)

  • Lamivudine 150mg plus stavudine 30 mg and nevirapine 200 mg tablet (CIPLA), bottle (60)

  • Lamivudine 150 mg tablet (GSK), 10 mg/ml oral solution (GSK), bottle (60) and bottle (240 ml), respectively

  • Lamivudine 150 mg tablet (Hetero), blister (10), bottle (60)

  • Lamivudine 150 mg tablet (Strides), blister (10), bottle (60)

Share